BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FONR
3851
DELISTED
Fonar
FONR
| $5.09K | ﹤0.01% |
238
+236
| +11,800% | +$4.83K |
|
|
IMDX
3852
Insight Molecular Diagnostics
IMDX
$130M
| $5.08K | ﹤0.01% |
133
-203
| -60% | -$10.5K |
|
3853
BGSF Inc
BGSF
$59.2M
| $5.07K | ﹤0.01% |
448
-2,626
| -85% | -$26.9K |
|
3854
NextDecade
NEXT
$1.86B
| $5.06K | ﹤0.01% |
2,344
-1,506
| -39% | -$2.75K |
|
3855
Rocky Brands
RCKY
$355M
| $5.06K | ﹤0.01% |
246
-1,920
| -89% | -$38.2K |
|
3856
Shinhan Financial Group
SHG
$35.5B
| $5.05K | ﹤0.01% |
210
-363
| -63% | -$8.89K |
|
3857
Lands' End
LE
$383M
| $5.05K | ﹤0.01% |
628
-2,950
| -82% | -$21.2K |
|
|
MPX
3858
DELISTED
Marine Products Corp
MPX
| $5.04K | ﹤0.01% |
364
-1,959
| -84% | -$20.6K |
|
3859
Aspen Aerogels
ASPN
$491M
| $5.04K | ﹤0.01% |
+766
| New | +$4.92K |
|
3860
Auburn National Bancorp
AUBN
$91.6M
| $5.02K | ﹤0.01% |
88
+75
| +577% | +$3.73K |
|
3861
Marker Therapeutics
MRKR
$19.2M
| $5.02K | ﹤0.01% |
243
-593
| -71% | -$13K |
|
3862
Information Services Group
III
$248M
| $5.01K | ﹤0.01% |
2,421
-8,703
| -78% | -$18.7K |
|
|
CHRA
3863
DELISTED
Charah Solutions, Inc Common Stock
CHRA
| $4.97K | ﹤0.01% |
156
-141
| -47% | -$2.44K |
|
|
BFIN
3864
DELISTED
BankFinancial
BFIN
| $4.95K | ﹤0.01% |
589
-3,740
| -86% | -$29.9K |
|
3865
Dianthus Therapeutics
DNTH
$6.25B
| $4.93K | ﹤0.01% |
41
-332
| -89% | -$46.8K |
|
|
CVLY
3866
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $4.92K | ﹤0.01% |
356
-2,588
| -88% | -$34.5K |
|
3867
RCI Hospitality Holdings
RICK
$233M
| $4.91K | ﹤0.01% |
354
-56
| -14% | -$684 |
|
3868
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.76B
| $4.9K | ﹤0.01% |
81
-465
| -85% | -$25.5K |
|
|
AGS
3869
DELISTED
PlayAGS
AGS
| $4.89K | ﹤0.01% |
1,446
-6,775
| -82% | -$25.9K |
|
|
YRD
3870
Yiren Digital
YRD
$103M
| $4.88K | ﹤0.01% |
1,182
-10,120
| -90% | -$40.2K |
|
|
AGTC
3871
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.86K | ﹤0.01% |
877
+875
| +43,750% | +$4.01K |
|
3872
Atomera
ATOM
$219M
| $4.83K | ﹤0.01% |
+537
| New | +$3.68K |
|
3873
Foster
FSTR
$408M
| $4.81K | ﹤0.01% |
377
-2,715
| -88% | -$34.9K |
|
3874
Mustang Bio
MBIO
$4.45M
| $4.8K | ﹤0.01% |
2
-10
| -83% | -$23.4K |
|
|
MMAC
3875
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $4.79K | ﹤0.01% |
207
-1,274
| -86% | -$31.6K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.